Req. No. 1358 Page 1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
STATE OF OKLAHOMA
1st Session of the 59th Legislature (2023)
SENATE BILL 217 By: Hamilton
AS INTRODUCED
An Act relating to health care; requiring licensed
practitioners to offer pharmacogenomic test prior to
prescription of psyc hotropic drugs; requiring certain
disclosures and obtainment of informed consent;
directing order and administration of pharmacogenomic
test; providing for codificat ion; and providing an
effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOM A:
SECTION 1. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 7201 of Title 63, unless there
is created a duplication in numbering, reads a s follows:
A. A licensed practitioner shall, prior to the prescription of
any psychotropic drug to a patient, offer to administer a
pharmacogenomic test to the patien t for the purpose of guiding the
decisions of the licensed practitioner with respect to how the
patient’s genes may react to certain medicat ions.
B. The licensed practitioner shall , to the best of the licensed
practitioner’s knowledge, inform the patient of the efficacy of
pharmacogenomic testing. The licensed practitioner shall inform the
Req. No. 1358 Page 2 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
patient of whether or not the pharmacogenomic test to be
administered is approved by the Food and Drug Administration. The
licensed practitioner shall obtain the patient ’s informed consent
prior to ordering a pharmacogenomic test. If the practitioner is
aware of the cost of the pharmacogenomic test, the practitioner
shall provide an estimate to the patient of such cost.
C. If a patient provides informed consent to receive a
pharmacogenomic test, the lic ensed practitioner shall o rder the
pharmacogenomic test and administer such test to the patient prior
to the prescription of any psychotropic medication .
SECTION 2. This act shall become effective November 1, 202 3.
59-1-1358 DC 1/9/2023 5:41:08 PM